Lookup NU author(s): Professor Konstantinos Stellos
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
© 2015 The Alzheimer's Association.Background Calpain has been associated with the pathophysiology of Alzheimer's disease (AD) and with apoptotic neuronal cell death leading to microparticles (MPs) formation. Methods A total of 64 patients with AD and 52 age- and gender-matched cognitively healthy elderly controls were included in the study. We measured calpain activity and levels of MPs, amyloid beta (Aβ1-42), h-tau, and p-tau181. Results AD patients showed significantly increased calpain activity and higher levels of MPs in cerebrospinal fluid (CSF) and significantly decreased calpain activity and lower levels of MPs in serum and plasma compared with healthy controls. Combined assessment of calpain activity and Aβ1-42 levels in CSF improved diagnostic accuracy as compared with singular or combined traditional CSF biomarkers of AD. Conclusions This is the first study showing increased calpain activity and microparticle levels in CSF of AD patients. Calpain activity could represent a novel diagnostic and prognostic biomarker and promising treatment target for AD.
Author(s): Laske C, Stellos K, Kempter I, Stransky E, Maetzler W, Fleming I, Randriamboavonjy V
Publication type: Article
Publication status: Published
Journal: Alzheimer's and Dementia
Online publication date: 04/09/2014
Acceptance date: 04/09/2014
ISSN (print): 1552-5260
ISSN (electronic): 1552-5279
Publisher: Elsevier Inc.
PubMed id: 25200336
Altmetrics provided by Altmetric